Stanford University School of Medicine: Inhibiting Enzyme Could Halt Cell Death in Parkinson's Disease, Study Finds
July 02, 2025
July 02, 2025
STANFORD, California, July 2 (TNSjou) -- Stanford University School of Medicine issued the following news:
* * *
Inhibiting enzyme could halt cell death in Parkinson's disease, study finds
Stanford Medicine-led research in mice indicates that inhibiting the LRRK2 enzyme could stabilize patients with a type of Parkinson's disease.
Editor's note: Neurons (blue) rooted in the substantia nigra provide dopamine (dark green dots) to st . . .
* * *
Inhibiting enzyme could halt cell death in Parkinson's disease, study finds
Stanford Medicine-led research in mice indicates that inhibiting the LRRK2 enzyme could stabilize patients with a type of Parkinson's disease.
Editor's note: Neurons (blue) rooted in the substantia nigra provide dopamine (dark green dots) to st . . .